Digestive Diseases and Sciences

, Volume 55, Issue 6, pp 1791–1793

Regression of B-Cell Lymphoma of the Liver with Hepatitis C Virus Infection After Treatment with Pegylated Interferon-α and Ribavirin

Authors

  • Yayoi Oda
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Masaki Watanabe
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Yojiro Sakuma
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Nori Taguchi
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Yoko Kato
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Yasushi Kudo
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Atsushi Yamauchi
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Yasushi Sugiura
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Shinya Ohashi
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Masanori Asada
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Toyokazu Fukunaga
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Kiyotaka Kawaguchi
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Hiroaki Ito
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
  • Takefumi Nakamura
    • Department of GastroenterologyTenri Hospital
  • Shujiro Yazumi
    • Digestive Disease Center, The Tazuke Kofukai Medical Research InstituteKitano Hospital
Case Report

DOI: 10.1007/s10620-009-0902-5

Cite this article as:
Oda, Y., Kou, T., Watanabe, M. et al. Dig Dis Sci (2010) 55: 1791. doi:10.1007/s10620-009-0902-5

Keywords

HCVInterferonLymphomaRibavirin

Copyright information

© Springer Science+Business Media, LLC 2009